Ozzy Osbourne's Final Hours: Paramedics Reveal Heartbreaking Details
Heavy metal legend passed away on Tuesday, July 22 at 76, and now, details of his final moments are coming to light. Paramedics reportedly worked for hours to save the rock legend's life after responding to a medical emergency at his home.
Air Ambulance Rushed to Ozzy Osbourne's Estate
"We can confirm that our helicopter was dispatched to provide advanced critical care at an incident near Chalfont St Giles yesterday," a spokesperson for Thames Valley Air Ambulance allegedly told the Daily Mail.
The emergency response began when a helicopter was reportedly dispatched to a field near the Black Sabbath frontman's estate around 10:30 a.m., according to the outlet.
In a desperate race against time, medics attempted to save the singer's life for "two hours," but were ultimately unsuccessful in reviving the heavy metal icon.
Locals told the outlet they grew concerned when they saw the aircraft overhead, fearing 'something serious was happening.' One resident shared to the outlet, 'We immediately feared it may be for him, as he was known to be in fragile health.'
Did Ozzy Osbourne Die From Parkinson's Disease?
Although the official cause of death has not been confirmed, it is believed to be connected to his long-standing battle with Parkinson's disease.
The 'Prince of Darkness' revealed his stage 2 diagnosis during an interview with Good Morning America in 2020. "It's been terribly challenging for us all," Ozzy said. "I got a numbness down this arm for the surgery; my legs keep going cold."
"I don't know if that's the Parkinson's or what, you know, but that's — see, that's the problem. Because they cut nerves when they did the surgery. I'd never heard of nerve pain, and it's a weird feeling," he detailed.
Sharon Osbourne's Heartbreaking Statement About Ozzy Osbourne's Death
"It is with more sadness than mere words can convey that we have to report that our beloved Ozzy Osbourne has passed away this morning," his wife, , said in a statement, signed by his children Aimee Osbourne, Kelly Osbourne, Jack Osbourne and Louis Osbourne.
"He was with his family and surrounded by love. We ask everyone to respect our family privacy at this time."
Ozzy Osbourne's Final Hours: Paramedics Reveal Heartbreaking Details first appeared on Parade on Jul 24, 2025
This story was originally reported by Parade on Jul 24, 2025, where it first appeared.
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
Musk's Neuralink to test brain chips in clinical study in Great Britain
(Reuters) - Elon Musk's brain implant company Neuralink said on Thursday it will launch a clinical study in Great Britain to test how its chips can enable patients with severe paralysis to control digital and physical tools with their thoughts. The company is partnering with the University College London Hospitals trust and Newcastle Hospitals to conduct the study, it said in a post on X. Neuralink said patients living with paralysis due to conditions such as spinal cord injury and a nervous system disease called Amyotrophic Lateral Sclerosis (ALS) qualify to participate in the study. The company raised $650 million in its latest funding round last month. It began human trials in 2024 on its brain implant after resolving safety concerns flagged by the U.S. Food and Drug Administration, which had initially rejected Neuralink's application in 2022. According to the company, five patients with severe paralysis are currently using its device to control digital and physical tools with their thoughts. Neuralink, founded in 2016, has raised about $1.3 billion from investors and is valued at roughly $9 billion, according to media reports, citing PitchBook.
Yahoo
8 minutes ago
- Yahoo
ImmunityBio, Inc. (IBRX) Gains UK Approval for ANKTIVA in Bladder Cancer
We recently compiled a list of ImmunityBio, Inc. stands eleventh on our list. ImmunityBio, Inc. (NASDAQ:IBRX) is one of the best future stocks to buy now. It is transforming cancer care through immunotherapies that activate the body's natural defenses. Its lead therapy, ANKTIVA (nogapendekin alfa inbakicept), has already been approved by the FDA for treating certain types of bladder cancer. The company is now expanding its approach with a focus on reversing lymphopenia, an immune deficiency often caused by chemotherapy, radiation, or immunotherapy. In June 2025, the FDA authorized an Expanded Access Program for ANKTIVA under the Cancer BioShield platform, making it the first approved therapy to target treatment-induced lymphopenia in patients with solid tumors who failed standard therapies. At ASCO 2025, data showed that restoring immune health with ANKTIVA, especially when paired with CAR-NK therapy, can significantly improve survival in metastatic pancreatic cancer patients. Internationally, ImmunityBio, Inc. (NASDAQ:IBRX) is gaining momentum. In July 2025, the UK approved ANKTIVA with BCG for non-muscle invasive bladder cancer (NMIBC), marking its first approval outside the U.S. Additionally, a partnership with Saudi Arabia's health system will bring the Cancer BioShield platform to the Middle East. The company is also expanding clinical trials, including a U.S.-based study testing ANKTIVA with PD-1 inhibitors in non-small cell lung cancer (NSCLC), with plans to expand globally. Meanwhile, the business is seeking broader FDA approval for ANKTIVA + BCG in bladder cancer after addressing regulatory hurdles. A laboratory technician using high tech equipment to sequence cancer genomics. By targeting immune collapse caused by cancer treatments, ImmunityBio, Inc. (NASDAQ:IBRX) is introducing a paradigm shift, fighting both cancer and immune dysfunction simultaneously. With FDA designations, strategic global alliances, and promising clinical data, the company is advancing a potentially life-extending new standard in oncology. While we acknowledge the potential of GOOGL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Bloomberg
11 minutes ago
- Bloomberg
Neuralink Launches Clinical Trial in Britain to Test Brain Chip
Neuralink Corp., Elon Musk's brain implant company, is launching a clinical trial in Great Britain to further test its device that allows people to control computers and other electronics with their brains. The trial will evaluate the safety and functionality of the device in as many as seven patients who have neurological conditions that impair their ability to use electronics, according to an announcement from University College London Hospitals, one of the research sites.
